Syndax Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.

About SNDX

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. 

CEO
Michael A. Metzger
CEOMichael A. Metzger
Employees
270
Employees270
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2005
Founded2005
Employees
270
Employees270

SNDX Key Statistics

Market cap
1.84B
Market cap1.84B
Price-Earnings ratio
-5.85
Price-Earnings ratio-5.85
Dividend yield
Dividend yield
Average volume
1.31M
Average volume1.31M
High today
$21.46
High today$21.46
Low today
$20.71
Low today$20.71
Open price
$21.04
Open price$21.04
Volume
698.62K
Volume698.62K
52 Week high
$22.73
52 Week high$22.73
52 Week low
$8.58
52 Week low$8.58

Stock Snapshot

The current Syndax Pharmaceuticals(SNDX) stock price is $21.12, with a market capitalization of 1.84B. The stock trades at a price-to-earnings (P/E) ratio of -5.85.

As of 2026-02-13, Syndax Pharmaceuticals(SNDX) stock has fluctuated between $20.71 and $21.46. The current price stands at $21.12, placing the stock +2.0% above today's low and -1.6% off the high.

The Syndax Pharmaceuticals(SNDX)'s current trading volume is 698.62K, compared to an average daily volume of 1.31M.

During the past year, Syndax Pharmaceuticals(SNDX) stock moved between $8.58 at its lowest and $22.73 at its peak.

During the past year, Syndax Pharmaceuticals(SNDX) stock moved between $8.58 at its lowest and $22.73 at its peak.

SNDX News

Simply Wall St 6h
Have Insiders Sold Syndax Pharmaceuticals Shares Recently?

Anyone interested in Syndax Pharmaceuticals, Inc. ( ) should probably be aware that the CEO & Director, Michael Metzger, recently divested US$361k worth of shar...

Have Insiders Sold Syndax Pharmaceuticals Shares Recently?
TipRanks 3d
Top Syndax Insiders Quietly Cash Out in Eye-Catching Stock Moves

New insider activity at Syndax Pharmaceuticals ( (SNDX) ) has taken place on February 10, 2026. Syndax Pharmaceuticals insiders have recently trimmed their hol...

Analyst ratings

100%

of 14 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own SNDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.